Efficacy and Safety of Sarecycline in Chinese Patients with Moderate-to-Severe Acne Vulgaris: Randomized Phase 3 Clinical Trial with Open-Label Follow-Up
Authors
Ying Tu (ORCID: https://orcid.org/0000-0001-7770-9876)
Efficacy and Safety of Sarecycline in Chinese Patients with Moderate-to-Severe Acne Vulgaris: Randomized Phase 3 Clinical Trial with Open-Label Follow-Up
Ying Tu, Belchin Kostov, Tolga Baykal, Jianzhong Zhang et al.
Citations
1 citations
Journal
Dermatology and Therapy
Topics
Acne and Rosacea Treatments and Effects
Field-Weighted Citation Impact (FWCI)
2.00
article
Efficacy and Safety of Sarecycline in Chinese Patients with Moderate-to-Severe Acne Vulgaris: Randomized Phase 3 Clinical Trial with Open-Label Follow-Up
Ying Tu, Belchin Kostov, Tolga Baykal, Jianzhong Zhang, Chen Xue, Esther García Gil, Li He, Judit Cabedo
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Dermatology and TherapyVol. 15(11)
Institutions
Peking University (CN), Kunming Medical University (CN), First Affiliated Hospital of Kunming Medical University (CN), Almirall (Spain) (ES), Peking University People's Hospital (CN)